Remission InductionRemission, SpontaneousAntirheumatic AgentsTreatment OutcomeTosyl CompoundsImmunosuppressive AgentsArthritis, RheumatoidAntibodies, Monoclonal, Murine-DerivedRecurrenceCyclophosphamideFollow-Up StudiesAntibodies, MonoclonalTime FactorsCytarabineLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsVincristinePrecursor Cell Lymphoblastic Leukemia-LymphomaPrednisoneCombined Modality TherapyDaunorubicinPrednisoloneTransplantation, AutologousMethotrexatePrognosisBone Marrow TransplantationLeukemia, LymphoidLeukemia, MyeloidDisease-Free SurvivalNephrotic SyndromeMesalamineNeoplasm, ResidualColitis, UlcerativeHematopoietic Stem Cell TransplantationDrug Administration ScheduleAcute DiseaseTransplantation, HomologousSurvival AnalysisDoxorubicinThioguanineDrug Therapy, CombinationAsparaginase6-MercaptopurineBone MarrowEtoposideLeukemia, Promyelocytic, AcuteLeukemiaCrohn DiseaseIdarubicinAntineoplastic AgentsLymphoma, Non-HodgkinRetrospective StudiesSalvage TherapySurvival RateHodgkin DiseaseSeverity of Illness IndexDepressive Disorder, MajorProspective StudiesPituitary ACTH HypersecretionWegener GranulomatosisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCladribineAminosalicylic AcidsMelphalanVidarabineTransplantation ConditioningProcarbazineAzathioprineGastrointestinal AgentsGlomerulonephritis, MembranousBleomycinGraft vs Host DiseaseLymphoma, FollicularActuarial AnalysisMechlorethamineSulfasalazineAnti-Inflammatory AgentsWhole-Body IrradiationDisease ProgressionNeoplasm Recurrence, LocalAntidepressive AgentsGlucocorticoidsBone Marrow PurgingLeukocyte CountPulse Therapy, DrugCitalopramOxidesPsychiatric Status Rating ScalesMultiple MyelomaAdrenal Cortex HormonesDrug EvaluationClinical Trials as TopicMyelodysplastic SyndromesNephrosis, LipoidLymphomaCyclosporinePlasmapheresisAntithyroid AgentsChlorambucilVasculitis